{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:07:36Z","timestamp":1788667656440,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijantimicag.2026.107769","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:19:49Z","timestamp":1772785189000},"page":"107769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Access to new antibacterials in 10 Asian countries: An Asian network for surveillance of resistant pathogens study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0874-9054","authenticated-orcid":false,"given":"Young Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-6615","authenticated-orcid":false,"given":"Helmi bin","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visanu","family":"Thamlikitkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Chien","family":"Lye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sock Hoon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Sia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamuna Devi","family":"Bakthavatchalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsun","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hui","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuk-Ying","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohaidah","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syamhanin","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azri Bin","family":"Nasruddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Shimono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0153-9852","authenticated-orcid":false,"given":"Nina Dwi","family":"Putri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evi","family":"Pratama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yae Jean","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9267-101X","authenticated-orcid":false,"given":"Doo Ryeon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hoon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5140-3964","authenticated-orcid":false,"given":"Kyungmin","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107769_bib0001","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","author":"Collaborators","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0002","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02000-20","article-title":"Epidemiology of carbapenem resistance determinants identified in meropenem-nonsusceptible enterobacterales collected as part of a Global surveillance program, 2012 to 2017","volume":"65","author":"Kazmierczak","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0003","doi-asserted-by":"crossref","first-page":"ofad649","DOI":"10.1093\/ofid\/ofad649","article-title":"The global and regional prevalence of hospital-acquired carbapenem-resistant Klebsiella pneumoniae infection: a systematic review and meta-analysis","volume":"11","author":"Lin","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00042-16","article-title":"Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia","volume":"30","author":"Hsu","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0006","doi-asserted-by":"crossref","first-page":"ofz194","DOI":"10.1093\/ofid\/ofz194","article-title":"Antimicrobial resistance or delayed appropriate therapy-does one influence outcomes more than the other among patients with serious infections due to carbapenem-resistant versus carbapenem-susceptible Enterobacteriaceae?","volume":"6","author":"Lodise","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0007","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ajic.2014.02.013","article-title":"Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis","volume":"42","author":"Bogan","year":"2014","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0008","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12879-017-2383-z","article-title":"Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis","volume":"17","author":"Zilberberg","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0009","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/cix783","article-title":"Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae","volume":"66","author":"van Duin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/cid\/ciu213","article-title":"Colistin and polymyxin B: peas in a pod, or chalk and cheese?","volume":"59","author":"Nation","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0011","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0012","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10081743","article-title":"New-generation antibiotics for treatment of gram-positive infections: a review with focus on endocarditis and osteomyelitis","volume":"10","author":"Bloem","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0014","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/cid\/ciab612","article-title":"Patient access in 14 high-income countries to new antibacterials approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020","volume":"74","author":"Outterson","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0015","unstructured":"The World Bank. GDP (current US$). 2024. https:\/\/data.worldbank.org\/indicator\/NY.GDP.MKTP.CD [accessed 27.08.25]."},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0016","unstructured":"The World Bank. GDP per capita (current US$). 2024. https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD [accessed 27.08.25]."},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0017","series-title":"World Population Prospects 2024","article-title":"Population Division","year":"2024"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0018","unstructured":"International Monetary Fund. GDP\/GDP per capita, current prices. 2024. https:\/\/www.imf.org\/external\/datamapper\/NGDPDPC@WEO\/TWN [accessed 27.08.25]."},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0019","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1370\/afm.1484","article-title":"A view of health care around the world","volume":"11","author":"Wallace","year":"2013","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0020","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1016\/S1473-3099(19)30284-1","article-title":"Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials","volume":"19","author":"Lanini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0021","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2352-4642(20)30365-5","article-title":"Harmonising regulatory approval for antibiotics in children","volume":"5","author":"Williams","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107769_bib0022","doi-asserted-by":"crossref","first-page":"107113","DOI":"10.1016\/j.ijantimicag.2024.107113","article-title":"Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020-2022)","volume":"63","author":"Sader","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0023","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Diseases Society of America guidance on the treatment of AmpC beta-lactamase-producing enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02000-21","article-title":"Geographic patterns of carbapenem-resistant Pseudomonas aeruginosa in the Asia-Pacific Region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) Program, 2015-2019","volume":"66","author":"Lee","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00405-23","article-title":"Ceftolozane-Tazobactam versus Ceftazidime-Avibactam for the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa: a multicenter cohort study","volume":"67","author":"Almangour","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0026","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0027","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s40265-023-01920-6","article-title":"Sulbactam\/Durlobactam: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0028","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for clostridioides difficile infection in adults","volume":"27","author":"van Prehn","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0029","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4269\/ajtmh.21-1167","article-title":"Epidemiology of Clostridium (Clostridioides) difficile infection in Southeast Asia","volume":"107","author":"Khun","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0030","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01290-24","article-title":"Global, regional, and national burdens of Clostridioides difficile infection over recent decades: a trend analysis informed by the global burden of disease study","volume":"13","author":"Zhou","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0031","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1017\/ice.2018.139","article-title":"Cost-effectiveness of three different strategies for the treatment of first recurrent Clostridium difficile infection diagnosed in a community setting","volume":"39","author":"Lam","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0032","series-title":"The root causes of unavailability of innovative medicines and delays in access","year":"2025"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0033","doi-asserted-by":"crossref","first-page":"ofaa464","DOI":"10.1093\/ofid\/ofaa464","article-title":"Buying time: the AMR Action Fund and the State of antibiotic development in the United States 2020","volume":"7","author":"Clancy","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0034","unstructured":"Public Health Agency of Sweden. A Swedish pilot study of an alternative reimbursement model. https:\/\/www.folkhalsomyndigheten.se\/contentassets\/700919bb88944affbfe814c1b23e53ed\/availability-to-antibiotics-of-particular-importance.pdf [accessed 20 .01.24]."},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0035","series-title":"Overview of Health Technology Assessment Processes for Time-Limited Recommendations: CADTH Health Technology Review","article-title":"CADTH Health Technology Review","author":"Mendell","year":"2023"},{"key":"10.1016\/j.ijantimicag.2026.107769_bib0036","unstructured":"Forum DG. Optimizing ASEAN joint assessment. 2025. https:\/\/globalforum.diaglobal.org\/issue\/april-2025\/optimizing-asean-joint-assessment\/(accessed [accessed 15.11.25]."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T19:03:26Z","timestamp":1779735806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0924857926000580"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107769","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Access to new antibacterials in 10 Asian countries: An Asian network for surveillance of resistant pathogens study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107769"}}